We read the letter to the editor by Bajpai R.[1] with great interest. The comments given by the author on the conduct and quality of reporting of the RCTs in India are valid in a general setting, but our article has been cited for these comments. We think this may be by mistake. The comments are mainly regarding design, sample size estimation, method of randomization, statistical analysis, and adherence to CONSORT guidelines. The sample size estimation was done before the start of the trial, and the same has been mentioned in the paper as well. As this was a community-based trial, block randomization was done where villages were taken as a block, and the same has been explained in the paper under the appropriate heading. The CONSORT guidelines were followed and the manuscript was written as per the guidelines.
The author has also mentioned that findings from this trial may impact the decision-making on the use of vitamin D to prevent incidence of diabetes in prediabetic women. We have also clearly recommended that larger studies with more precision are required to capture the effect of vitamin D supplementation on the incidence of diabetes.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
Reference
- 1.Bajpai R. Methodological quality and reporting of randomised controlled trials published in Indian medical journals. J Family Med Prim Care. 2022;11:1584–5. doi: 10.4103/jfmpc.jfmpc_1741_21. [DOI] [PMC free article] [PubMed] [Google Scholar]